Press Releases
GT Biopharma to Present at Roth Capital Partners 30th Annual Conference
GT Biopharma (GTBP: OTCQB) Announces Appointment of Shawn M Cross as Chairman and Chief Executive Officer
GT Biopharma Announces Dr. Jeffrey Miller, Renowned NK Cell Cancer Specialist, Will Present at Cell Therapy Symposia
GT Biopharma, Inc. Issues Letter to Shareholders
GT Biopharma Announces $7.1 Million Convertible Debt Financing
Geoffrey B. Davis Joins GT Biopharma's Board of Directors
GT Biopharma Announces Completion of Dosing in Phase 1 Clinical Trial of GTP-004 for Myasthenia Gravis
GT Biopharma, Inc. Files Application for NASDAQ Capital Market Listing
GT Biopharma, Inc. Starts FDA Phase 1 Clinical Trial for Myasthenia Gravis Autoimmune Muscular Disease
